Treatments

Healthy lifestyle lowers the risk of post-COVID complications, finds study (medicalxpress.com)

... the study found that individuals with a favorable lifestyle had a lower risk of hospitalization, lower incidence of long-term or on-going health issues affecting multiple parts of the body, and reduced risk of post-COVID death, compared to those with an unfavorable lifestyle.

...

If You're Experiencing Any Of These COVID Symptoms, Doctors Say You Should Seek Medical Attention ASAP There are some COVID-19 symptoms that aren’t normal. View Entire Post › BuzzFeed

...

Experts share what COVID-related issues should be instant red flags, plus some advice on what to do:

Researchers draw insights from COVID-19 to inform improved health care in times of crisis (medicalxpress.com)

In research recently published in Nature Medicine, Rensselaer Polytechnic Institute's Jianxi Gao, Ph.D., associate professor of computer science, and his team measured the resilience and adaptability of our health care system to disruptions caused by COVID-19. Resilience is a system's ability to absorb and recover from disruptions. Adaptability is a system's ability to learn from previous disturbances where there are recurrent disruptions. ...

"We found that our health care systems in the United States exhibit substantial adaptability, but only a moderate level of resilience," said Gao. "Our findings can inform the design of resilient and sustainable health care systems to prepare for future disruptions, whether they are caused by pandemics, climate change, conflicts, or anything else."

...

Paxlovid led to better outcomes in hospitalized COVID cohort than Veklury or both drugs Hospitalized COVID-19 patients treated with the antiviral drug nirmatrelvir–ritonavir (Paxlovid) are at lower risk for death, intensive care unit (ICU) admission, and need for ventilation than those given a combination of Paxlovid and the antiviral drug remdesivir (Veklury) or Veklury alone, a University of Hong Kong target trial emulation study suggests. CIDRAP

...